SEISMIC Trial

Related by string. * seismics . Seismic . seismic : 3D seismic . seismic upheaval due . Ingram Micro Seismic . 2D seismic . seismic shift . kilometer 2D seismic . SEISMIC / trialed . trialing . trials . Trials . trial . TRIAL : Phase III clinical trials . Week Premium Trial . Phase III trials . placebo controlled clinical trials . randomized controlled trial . randomized controlled trials * *

Related by context. All words. (Click for frequent words.) 66 CYPHER Stent 63 SCIg 62 oxycodone CR 62 ACR# responses 62 CIMZIA ™ 62 placebo dexamethasone 62 ACTEMRA TM 62 PASI scores 62 relapsed MM 62 echocardiographic parameters 61 dacarbazine chemotherapy 60 aldosterone antagonist 60 achieved ACR# 60 oral diclofenac 60 ARCALYST ® 60 glycated hemoglobin HbA1c 60 RECORD1 60 probiotic supplementation 60 osteoporotic vertebral fractures 60 trastuzumab Herceptin ® 59 Nonresidential structures 59 HIV HCV coinfected 59 CIPN 59 complete cytogenetic response 59 patients undergoing CABG 59 postoperative mortality 59 titrated glipizide 59 pharmacokinetic characteristics 59 certolizumab 59 Pharmacokinetic parameters 59 intravenous bisphosphonates 59 prednisone prednisolone plus 59 NATRECOR R 59 lipid lowering agents 59 resected pancreatic cancer 59 Mg Uk 59 antiretroviral naïve 59 Dr. Roehrborn 59 oxcarbazepine 59 ketorolac 59 Platelet counts 59 microbiological eradication 59 Doxil ® 58 trials RCTs 58 NMDA receptor antagonists 58 rectal tenesmus 58 octreotide LAR 58 CANCIDAS 58 vincristine doxorubicin 58 KRAS mutations occur 58 paricalcitol 58 morphometric vertebral fractures 58 undergone radical prostatectomy 58 recurrent GBM 58 topical NSAIDs 58 pancreatic adenocarcinoma 58 episodic migraine sufferers 58 APTIVUS r 58 MERIT ES 58 nondepressed 58 dose pravastatin 58 oncologic outcomes 58 FOLFOX4 58 Renal Cell Carcinoma RCC 58 locoregional recurrence 58 dalteparin 58 tocilizumab 58 tonsillar hypertrophy 58 prospective multicentre 58 infliximab monotherapy 58 -#.# log# copies mL 58 thyrotropin levels 58 Wisconsin Sleep Cohort 58 PSADT 58 NATRECOR ® 58 GnRH agonists 58 postoperative chemotherapy 58 genotypic resistance 58 % Confidence Interval 57 standard chemotherapy regimen 57 antioxidant supplementation 57 gp# vaccine 57 Deutsches Arzteblatt International 57 retrospective cohort 57 PSA nadir 57 intracranial stenosis 57 coinfected patients 57 HER2 expression 57 desvenlafaxine succinate 57 poor metabolizers 57 CR nPR 57 β blockers 57 OAB symptoms 57 amisulpride 57 ritonavir boosted 57 cediranib 57 Refinery utilization rebounded 57 zoledronate 57 prospective nonrandomized 57 Currency translation negatively impacted 57 Hum Mol Genet 57 psoriatic arthritis PsA 57 clozapine Clozaril 57 low dose Iluvien 57 receiving golimumab 57 pulmonary capillary wedge 57 ASPS statistics 57 Subgroup analysis 57 BoNTA 57 Subgroup analyzes 57 carotid stenosis 57 serum lipid levels 57 antiemetics 57 XELOX 57 aldosterone antagonists 57 PDP MLR 57 Munghana Lonene Listenership 57 doxorubicin cyclophosphamide 57 dose proportionality 57 mycophenolate mofetil 57 CIN3 57 VaD 57 pCR 57 paclitaxel eluting stents 57 MMSE scores 57 tamoxifen Nolvadex ® 57 oral Hycamtin 57 Engerix B 57 #mg dose [002] 57 intravesical therapy 57 Euro Libor #.# 57 J Immunol 57 KRAS status 57 plus methotrexate 57 tamoxifen raloxifene 57 -#.# log# 57 nonmelanoma skin cancers 57 canakinumab 57 pyridostigmine 57 agomelatine 56 perioperative mortality 56 gadobutrol 56 neurologic complications 56 symptomatic carotid stenosis 56 Relapsing remitting MS 56 ratio ICER 56 ibandronate 56 tapentadol ER 56 MCyR 56 chlorambucil 56 pegylated interferons 56 rectal tenesmus #.# 56 Serious adverse reactions 56 glargine 56 CVD mortality 56 oral antidiabetic medication 56 Index CDAI 56 Available Seat Kilometres ASKs 56 ACUITY trial 56 alfuzosin 56 Arch Intern Med 56 mg BID dose 56 demonstrated clinically meaningful 56 Velcade bortezomib 56 protease inhibitor PI 56 dose Iluvien 56 elevated ALT 56 antiangiogenic therapy 56 ginkgo extract 56 Spinal manipulation 56 venlafaxine Effexor 56 Paroxysmal Nocturnal Hemoglobinuria PNH 56 Viread Emtriva 56 tipranavir ritonavir 56 UPDRS motor 56 unresectable tumors 56 tipranavir 56 SYNERGY Stent 56 rimonabant #mg 56 microalbumin test 56 irinotecan cisplatin 56 oral rivaroxaban 56 Schizophrenia Bulletin 56 BEXXAR Therapeutic Regimen 56 mean ± SEM 56 idraparinux 56 visceral metastases 56 onset atrial fibrillation 56 Am J Gastroenterol 56 ICSI cycles 56 relapsing remitting MS RRMS 56 cytogenetic analyzes 56 therapeutic regimens 56 chronic prostatitis 56 interferon ribavirin 56 ARB telmisartan 56 Pertuzumab 56 gynecologic procedures 56 deCODE ProstateCancer TM 56 receiving VICTRELIS 56 relapsed SCLC 56 intact parathyroid hormone 56 transaminase elevations 56 receiving lifesaving antiretroviral 56 Operative mortality 56 mg RDEA# 56 BMC Musculoskeletal Disorders 56 Tumor shrinkage 56 sustained virological response 56 prelicensure 56 HbA 1c levels 56 prostate TURP 56 completely resected 56 NHANES III 56 ginkgo biloba extract 56 GI motility disorders 56 underwent resection 56 ARIXTRA 56 DLQI 56 DAS# scores 56 vitamin D inadequacy 56 MacroChem actual 56 bicalutamide 56 aspirin clopidogrel 56 tamsulosin 56 aripiprazole Abilify 56 Screening Trial DMIST 56 bezafibrate 56 EDSS scores 56 neuropathy sensory 56 revascularization procedures 56 Electroencephalography 56 lipid lowering drugs 56 FOLFIRINOX 56 osteopathic manipulation 56 ATACAND 56 subclinical hyperthyroidism 55 interpersonal psychotherapy 55 solid tumors ZYBRESTAT 55 Bayer HealthCare Onyx Pharmaceuticals 55 median survivals 55 quetiapine risperidone 55 renal cell carcinomas 55 osteosarcomas 55 solifenacin 55 goserelin 55 glomerular filtration 55 albumin excretion rate 55 LLLT 55 spirometric 55 mcg albinterferon alfa 2b 55 HORIZONS AMI trial 55 seminoma 55 carboplatin paclitaxel 55 Antipsychotic medications 55 radiographic outcomes 55 angiotensin II receptor blockers 55 clodronate 55 Univariate analysis 55 hypogonadal men 55 interferon alfa 55 neurosensory 55 opioid naïve 55 left ventricular diastolic 55 paroxetine sertraline 55 RISPERDAL ® 55 Crohn Disease Activity 55 Neoadjuvant 55 meta regression 55 preoperative chemotherapy 55 Alimentary Tract 55 steroid dexamethasone 55 VFEND 55 hepatic lesions 55 interferon alfa 2b 55 subtrochanteric 55 CINQUIL 55 oral clodronate 55 LOW PRICE STOCK 55 hip BMD 55 Dr. Gianni Belcaro 55 H#/# EUR 55 Meta analyzes 55 serotonin reuptake inhibitors 55 Digital Mammographic Imaging 55 nonpharmacologic 55 HBeAg positive 55 MACCE 55 beta carotene supplementation 55 Tor Bjerkedal report 55 pexelizumab trials 55 Poisson regression 55 endoscopic remission 55 neoadjuvant therapy 55 mammographically 55 MIRAPEX 55 biochemical recurrence 55 timepoints 55 oxycodone IR 55 MCXCOMDEX trades 55 Symptom severity 55 TEAEs 55 hemoglobin A1c HbA1c 55 baseline HbA1c 55 EURIDIS 55 Schema Therapy 55 care regimens CCR 55 endocrine therapies 55 Cystatin C 55 PAH afflicts approximately 55 Paxil paroxetine 55 Riluzole 55 & s2 = 55 efavirenz Sustiva 55 Lumbar spine 55 tumor histology 55 stomatitis pharyngitis 55 antiandrogens 55 ritonavir boosted atazanavir 55 riociguat 55 Prostate specific antigen 55 metastatic gastric 55 Kaplan Meier analysis 55 DOI #.#/art.# 55 coronary calcification 55 extracolonic findings 55 #rd Annual CTRC 55 malignant pleural mesothelioma 55 BJU International 55 ejaculatory function 55 abdominal adiposity 55 osteoporotic vertebral compression fractures 55 INVEGA ® 55 virologic responses 55 verum acupuncture 55 paclitaxel Taxol R 55 sustained virologic response 55 hormone deprivation 55 ZOMIG Nasal Spray 55 chemotherapy gemcitabine 55 Carotid endarterectomy 55 fluvastatin 54 linear pharmacokinetics 54 antiangiogenic activity 54 XIENCE V PROMUS Stent 54 storied chateau 54 plus prednisone 54 salmeterol fluticasone 54 Zometa hazard 54 antiplatelet therapies 54 5-FU/LV 54 Hazard Ratio HR 54 tegaserod 54 allogeneic SCT 54 DAPT 54 advanced adenomas 54 hemoglobin A1c levels 54 metabolic parameters 54 HbA1C levels 54 vardenafil Levitra 54 postoperative pulmonary 54 OnDose TM 54 Evaporative Cooling segment 54 hepatic metastases 54 Dialysis Outcomes 54 Parnate 54 NPH insulin 54 Electro Rent NASDAQ ELRC 54 baseline FEV 54 levosimendan 54 osteoporotic compression fractures 54 PRADAXA #mg 54 antihypertensive drugs 54 DAS# remission 54 mg Pycnogenol 54 metastatic RCC 54 nabilone 54 GfK Polonia poll 54 Prelox 54 salivary cortisol 54 bendamustine 54 CPAP adherence 54 carotid IMT 54 conjugated equine estrogen 54 REYATAZ r arm 54 headache nasopharyngitis 54 PROCTOCORT ® Suppository Hydrocortisone 54 EECP therapy 54 Repliform R revenues 54 ALT elevation 54 melphalan prednisone 54 CIN2 + 54 Taxus Stent 54 X ray angiography 54 PCA3 scores 54 Merckx Hinault Miguel Indurain 54 Prepaid churn 54 hematopoietic cancers 54 radiotherapy RT 54 + PH# 54 YY =Anders Ostergaard 54 osteoarthritic pain 54 risedronate 54 paroxetine Paxil 54 Kantarjian 54 Dr. Cassian Yee 54 interferon gamma 1b 54 ImmuKnow assay 54 venlafaxine XR 54 atherosclerotic renal artery stenosis 54 aromatase inhibitors AIs 54 atorvastatin #mg 54 thoracoscopic lobectomy 54 ONGLYZA saxagliptin 54 Cancer Incidence Mortality 54 lipid parameters 54 nonrandomized studies 54 Prostatitis 54 topical retinoids 54 newer antipsychotics 54 Sees FY# adj EPS 54 brachial artery flow 54 adalimumab 54 DAS# CRP 54 hemoglobin A1C HbA1C 54 chemoradiation 54 intensive statin therapy 54 psychiatric outpatients 54 antimuscarinic 54 lenalidomide dexamethasone 54 iniparib 54 underwent surgical resection 54 seroconverted 54 was#.# 54 hamartomas 54 exploratory endpoints 54 attending antenatal clinics 54 glulisine 54 Baseline characteristics 54 conventional angiography 54 ADAS Cog 54 ziprasidone 54 transdermal estrogen 54 overactive bladder symptoms 54 Chronic Heart Failure 54 Secondary efficacy endpoints 54 FOLFOX4 alone 54 Jurgen Rehm 54 sleeve lobectomy 54 pregabalin 54 perioperative complications 54 urinary cortisol 54 methotrexate monotherapy 54 amalgam fillings mercury vapor 54 Ribavirin royalties 54 non squamous NSCLC 54 risperidone olanzapine 54 infliximab Remicade 54 binary restenosis 54 heavily pretreated 54 renal tumors 54 non squamous histology 54 Nasdaq Composite COMP #.# 54 amoxicillin clavulanate 54 malignant lesions 54 lipid lowering medications 54 adjunctive placebo 54 bronchial thermoplasty 54 EchoCRT 54 GYTS 54 MMSE score 54 SYNTAX Score 54 Removab 54 Endocrine Society #st 54 rosuvastatin Crestor 54 undergoing peritoneal dialysis 54 % mlink 54 By Katy Burne 54 EUS FNA 54 multimodality therapy 54 zoledronic acid 54 Billable headcount 54 irbesartan 54 Capacity FVC 54 strontium ranelate 54 ICD therapy 54 Resolute DES 54 Captive colonies 54 folinic acid 54 Multivariate analyzes 54 mineral density BMD 54 zolmitriptan 54 prescribed CRESTOR 54 cilostazol 54 Spira cites 54 cytoreductive surgery 54 adjuvant radiation 54 seroprotection 54 psychotherapeutic drugs 54 pessimists outnumber optimists 54 Nasdaq adv dec 54 Homocysteine levels 54 Urodynamics 54 HIV uninfected 54 pertuzumab 54 hydroxyvitamin D levels 54 #:#-# [029] 53 neutropaenia 53 NeuroStar TMS Therapy 53 Celiac disease affects 53 clinicopathological features 53 acamprosate 53 Diabetologia 53 evaluable subjects 53 dexmedetomidine 53 pentoxifylline 53 journal Transfusion 53 Triglyceride levels 53 Epidemiologic studies 53 Outpatient Setting 53 doxazosin 53 nonsmall cell lung cancer 53 Neogen NASDAQ NEOG 53 Acta Scandinavica 53 buprenorphine naloxone 53 CLBP 53 perinatal outcomes 53 metformin IR 53 RRMS patients 53 Nothing Wadden 53 risedronate Actonel 53 oral antidiabetic 53 tranylcypromine 53 QM MSP 53 Entitlement Mentality 53 metastatic lung cancer 53 Cochrane reviewers 53 testosterone supplementation 53 nonfasting triglyceride levels 53 HealthGrades analyzed 53 tolterodine ER 53 squalid tarp cities 53 ALISTA 53 sulphonylureas 53 somatoform disorders 53 BJOG An 53 GSPF slid 53 NAMCS 53 OshKosh wholesale 53 cardiac perfusion 53 microbiologically evaluable 53 HIV seronegative 53 laparoscopic bariatric surgery 53 Euler Hermes +#.# 53 Hepatocellular Carcinoma HCC 53 primidone 53 stavudine d4T 53 operable breast cancer 53 Psoriasis Area 53 Lancet Oncology journal 53 ASPS comprises 53 Multidetector CT MDCT 53 vasomotor symptoms 53 IELEC.T Quote NEWS 53 arterial thickening 53 Ginkgo extract 53 urine albumin 53 tricyclic antidepressant 53 sevelamer 53 aromatase inhibitor therapy 53 mineralized uncut 53 echinacea tablets 53 ACE Inhibitors 53 logistic regression analyzes 53 Annualized ROE 53 cabazitaxel 53 euthymic patients 53 indinavir 53 antibiotic rifaximin 53 bone grafting procedures 53 abacavir lamivudine 53 Adjuvant chemotherapy 53 NLX P# 53 buproprion 53 fever skin rashes 53 haematologic 53 Lou Sessinger column 53 stage IIIB IV 53 teriparatide 53 ejection fractions 53 demonstrated antitumor activity 53 OSAHS 53 Locum Tenens staffing 53 colon capsule endoscopy 53 FCHI Quote Profile 53 Valcyte tablets 53 colorectal cancer CRC 53 FFR guided 53 Inventories subtracted 53 clomipramine 53 ABCSG 53 abnormal cytology 53 clinically meaningful reductions 53 mainline passenger RASM 53 chest radiographs 53 candesartan 53 limiting generalizability 53 PANSS scores 53 hsCRP levels 53 Ejection Fraction 53 NYP-NEWS 53 overt hypothyroidism 53 urine cytology 53 somatic symptoms 53 lopinavir r 53 RE LY trial 53 Irrigated fields 53 venous thromboembolisms 53 Noninterest expense totaled 53 Sun.Star Pampanga newspaper 53 JAMA. 53 Histologic 53 Atomoxetine 53 comparator arm 53 Avandia Actos 53 -#.# Mio 53 Scale cognitive subscale 53 #mg doses [002] 53 co trimoxazole 53 Gefitinib 53 STACY LEE 53 EMPHASIS HF trial 53 SGS# 53 Percutaneous vertebroplasty 53 hyaluronic acid fillers 53 Atkins dieters cardiovascular 53 relapsed ALL 53 abdominal hysterectomy 53 subthreshold depression 53 invasive lobular 53 colorectal neoplasia 53 tiotropium 53 Consolidated PRASM 53 perfusion defects 53 febuxostat 53 IOVS 53 antiplatelet drugs 53 hip resurfacing arthroplasty 53 tibolone 53 NIASPAN 53 cytoreductive nephrectomy 53 URTI 53 PREZISTA r 53 journal Anticancer 53 Craftmade segment 53 Dynesys 53 CuEQ equals Cu 53 visilizumab 53 Emil Protalinski Published 53 sertraline Zoloft 53 haloperidol Haldol 53 basal cell carcinoma squamous 53 ticlopidine 53 stage hypoxia activated 53 cytogenetic response 53 acarbose 53 journal Arteriosclerosis Thrombosis 53 BY DAVID CRIGGER 53 CDAI score 53 PTNS 53 ANN INTERN MED 53 insulin detemir 53 Health NSDUH 53 HOMA IR 53 gallium arsenide GaAs substrate 53 ASIA ADRS 53 Complication rates 53 Keyes yearbook 53 Globicus qEcon EMU 53 journal Resuscitation 52 radioiodine therapy 52 Farfan Juan Pablo 52 multicenter multinational 52 workweek lengthened 52 ACEIs 52 CTD Jeopardy 52 Canadian Multicentre Osteoporosis 52 Yuegang Zuo professor 52 NutropinAq ® 52 Nephrology Dialysis Transplantation 52 adiponectin concentrations 52 Alessandro Riva 52 antiepileptics 52 dacarbazine 52 asymptomatic PAD 52 Randomized trials 52 Balloon Kyphoplasty 52 treated nonsurgically 52 ASCUS 52 placebo fluoxetine 52 Amir Lerman 52 Rural Mainstreet economic 52 Orthopedic Implants 52 Dabigatran 52 Cardiorespiratory fitness 52 insulin lispro 52 Inflammatory Bowel Diseases 52 journal Ophthalmology 52 lung ovary 52 randomized controlled trials RCTs 52 HCV antibody 52 Internationally EDC 52 cranial irradiation 52 Medcath NASDAQ MDTH 52 NCCN guidelines 52 ® bortezomib 52 RLS sufferers 52 tramiprosate Alzhemed TM 52 extracapsular extension 52 hormone therapy estrogen 52 statistically significant efficacy 52 Towering scholar 52 analgesic medications 52 metabolically healthy 52 BCIRG 52 LAST FIVE TRADING SESSIONS 52 radiation chemoradiation 52 relapsed ovarian cancer 52 OPANA franchise 52 FDG PET imaging 52 detectable BPA 52 flutamide 52 Implied vols 52 drinking beetroot juice 52 sulfasalazine 52 docetaxel chemotherapy 52 calculated creatinine clearance 52 Antiplatelet 52 Kaplan Meier estimates 52 Secondary endpoints include 52 HICPs 52 HER2 positive metastatic breast 52 anticholinergic drugs 52 O PPDS 52 ofpatients 52 By DEBORAH HIRSCH 52 Lynne Truss Gotham 52 varus deformity 52 H2 receptor antagonists 52 cardiovascular calcification 52 guaiac 52 Nonaccrual loans totaled 52 DAVID PAUL KUHN 52 Traficet EN 52 EGFR mutation positive 52 zidovudine lamivudine 52 retrospective observational study 52 intraobserver 52 hawthorn extract 52 autonomic dysfunction 52 Oncotype 52 PEG Intron 52 Sentix 52 locoregional 52 symptomatic fibroids 52 MAS XR 52 Diageo DEO #/#/# PriceWatch 52 Delinquency Bulletin 52 PegIntron 52 leukotriene receptor antagonists 52 plus COPEGUS 52 mean baseline A1C 52 UMich index 52 Zevalin consolidation 52 PLCO 52 glitazones 52 Isolaz procedures 52 ICDs implanted 52 azathioprine 52 RLAI 52 liver colon rectal 52 LATUDA 52 dosage regimens 52 follicular lymphoma FL 52 Kaplan Meier estimate 52 Depressed bipolar 52 radiofrequency ablation RFA 52 noninterest expense decreased 52 circulating endothelial cells 52 ION Stent 52 Cardiovasc Res 52 Prevalence Worldwide 52 severe mitral regurgitation 52 varicoceles 52 BR.# 52 FTSC FTSE 52 Colorectal cancer screening 52 droperidol 52 p = .# [002] 52 foberdieck@aercap.com pwortel@aercap.com 52 progression TTP 52 Hycamtin 52 visit http:/www.aberdeen.com/link/sponsor.asp?spiSautner ruled 52 GH deficiency 52 mineral density 52 Daniel Popko 52 Jon Kar Zubieta 52 factor PlGF 52 quetiapine Seroquel 52 XIENCE V stent 52 NEVO ™ 52 PSA kinetics 52 mm Hg diastolic 52 Bipolar Disorders 52 hypofractionated radiation 52 FOREXYARD Daily Forex 52 simulated acupuncture 52 Hershkowitz comprise 52 Rachel Manber 52 Gary Scelzi Dodge Stratus 52 Buglova 52 FFR measurements 52 Multivariate logistic regression 52 CHD mortality 52 clinically meaningful improvement 52 Harpo Studios produces 52 lamivudine monotherapy 52 reboxetine 52 MADRS score 52 antiandrogen 52 System IPSS 52 spironolactone 52 sodium valproate 52 comorbid depression 52 thyroglobulin 52 prazosin 52 recurrent miscarriage 52 By Alex Roarty 52 Fine needle aspiration 52 AVODART 52 metaanalysis 52 tacrolimus ointment 52 JEWELRY Down 52 rt PA 52 ULTRAM ER 52 CSDs Dr Pepper 52 pediatric malignancies 52 Rigid PCB shipments 52 null responder 52 anthracycline taxane 52 SuperMedia specializes 52 Nondurable goods orders 52 tricyclics 52 loop diuretics 52 monotherapies 52 Hb A1C 52 Fresher barometers however 52 HER2 positive breast 52 Surgeon Doug Elenz 52 By CINDY BARKS 52 reflux symptoms 52 Anders Wimo 52 Columnist Filip Bondy 52 histologic subtype 52 gefitinib Iressa 52 HIV tropism 52 HbA1c levels 52 unadjusted Purchase 52 Bergenstal 52 Surfactant gross 52 Temeraire novels increased 52 Cervista HPV HR 52 differentiated thyroid 52 nulliparous women 52 histologic subtypes 52 nonpregnant women 52 Noninterest Expense Noninterest expense 52 daily subcutaneous injections 52 By SCOTT RASMUSSEN 52 BODE index 52 esophageal reflux 52 WARNINGS Myopathy Rhabdomyolysis 52 pelvic malignancies 52 By Aja Carmichael 52 By PATTI ARNOLD 52 differential gene expression 52 gastric cancers 52 PROLARIS 52 Roger Pinate 52 Male Reproductive Medicine 52 Ovarian PLCO Cancer 52 prioryear 52 Sjögren syndrome 52 Dr. Kandzari 52 L thyroxine 52 Histopathological 52 Repertory Films 52 ADCS ADL 52 peginterferon alpha 2a 52 metabolite concentrations 52 James Cerhan MD 52 Orthomolecular 52 Vlachopoulos 52 breast carcinomas 52 erection hardness 52 Carvedilol 52 LC#m# vaccine 52 barometers flashed 52 advanced adenoma 52 Markit PMI 52 Clinical Diagnostics segment 52 angiogenesis inhibition 52 cabergoline 52 MARRIOTT REVENUES totaled 52 Virologic failure 52 CARDIA 52 By JENNIFER KOVACS 52 ITP.net Staff Writer 52 adverse reactions occurring 52 degenerative spondylolisthesis 52 tDCS 52 Severity Index PASI 51 thiazide diuretics 51 HoLEP 51 carboplatin chemotherapy 51 KRAS mutation 51 enalapril 51 tumor shrinkage 51 deCODE AF TM 51 histological subtypes 51 #.#ng/ml 51 AF ablation procedures 51 underwent liver transplantation 51 anticholinergics 51 Dennis abs cbnNEWS.com 51 ACS NSQIP 51 axillary node dissection 51 comorbid anxiety 51 odds ratios ORs 51 BRCA carriers 51 invasive coronary angiography 51 bone bruise Bettis 51 Eurozone ZEW 51 pazopanib 51 verdict elicited gasps 51 Severe Asthma 51 smallest tummies 51 HYVET 51 TCA Cellular Therapy 51 Kaplan Meier curve 51 stress cardiomyopathy 51 Echocardiographic 51 conventional antipsychotics 51 chemoprevention trials 51 Rheumatoid arthritis affects 51 cartilage lesions 51 INVEGA ™ 51 duplex ultrasonography 51 CompX Reports 51 EBUS FNA 51 immunosuppressive therapies 51 By EMILY MORRIS 51 dapsone 51 active comparator 51 heavily pretreated patients 51 anti JCV antibodies 51 MR arthrography 51 mg Lucentis 51 axillary lymph node dissection 51 glyburide 51 Fireworks resounded 51 BSGI MBI 51 psychiatric comorbidities 51 journal Molecular Psychiatry 51 noscapine 51 ShopperTrak calculations 51 chiropractic manipulation 51 EU Harmonised Index 51 ADCS CGIC 51 abnormal mammograms 51 overactive bladder OAB 51 nighttime awakenings 51 Complications Trial 51 pramlintide metreleptin combination 51 NIHSS 51 KATIE MINTZ 51 MDRD equation 51 MDRD 51 civilian noninstitutionalized population 51 invasive lobular carcinoma 51 Multivariable logistic regression 51 analgesic efficacy 51 DAVANAT R exhibits 51 virologically 51 #mg/day [001] 51 rituximab refractory 51 piotr.skolimowski @ thomsonreuters.com 51 Prozac fluoxetine 51 http:/www.harrisinteractive.com

Back to home page